Delivery Order SPE2DB22D2211-SPE2DB24FNYE9
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ozempic 0.25-0.5 mg/dose pens. The contract is a firm-fixed-price delivery order with a ceiling value of $50,768.51 and an ultimate completion date of September 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,227.80 and an ultimate completion date of August 16, 2024. AmerisourceBergen, through its Corporate Office division, will be responsible for delivering this pharmaceutical product to support federal healthcare programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $3,171.12, is a firm fixed-price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic (0.25-0.5 mg/dose) pens. The contract is a Firm Fixed Price Delivery Order with a total ceiling value of $9,740.97 and an ultimate completion date of September 25, 2024. AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to supply the DLA with this critical diabetes medication. This award...
This federal contract award, with a ceiling value of $4,487.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity. This is a firm fixed-price delivery order contract with an ultimate completion date of August 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,331.99, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 17, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,360.12, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of January 25, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity, valued at $19,568.94. The contract has a completion date of July 15, 2024 and is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order worth $1,749.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ozempic 0.25-0.5 mg/dose pens. The contract was awarded by the Defense Logistics Agency (DLA) on March 22, 2024 and has a firm fixed price with a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,902.70 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of August 26, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs)...